INTRODUCTION
Osteoporosis screening rates are known to be lower among black and Hispanic women than among white women. Previous studies have found 20-50% lower use of bone density screening for black women, and 23% less testing for Hispanic women. [1] [2] [3] Racial differences in screening are generally interpreted as indicators of poorer quality of care. 4 However, there are possible legitimate explanations for racial differences in osteoporosis screening among women who have not had a fracture. Fracture rates are substantially lower for black and Hispanic women than for white women, 5, 6 and good evidence for the ability of bone density to predict fracture in nonwhite women has been published only recently. 5, 6 Also, evidence for fracture reduction with osteoporosis treatment is very limited for racial minorities, as clinical trials have enrolled substantially white populations. [7] [8] [9] For these reasons, either doctors or patients might reasonably have concluded that bone density testing for primary screening offers uncertain benefits for minority women. The situation changes, however, once a fracture occurs. Hip fracture patients in a large longitudinal study had a recurrent fracture risk of 10.4 fractures/100 person-years, 1.6 times greater than controls even after adjustment for fracture risk factors. 10 There is no evidence that fracture recurrence rates vary by race. Therefore, once a fracture occurs, it is possible that a "catch-up" phenomenon in bone density testing could occur-that is that women who did not undergo primary screening prior to a fracture would receive testing after it. This should be especially true for Medicare patients with hip fractures, as hospitalization is almost universal and Medicare pays for testing. While an argument could be made for empiric osteoporosis treatment in this group, an empiric strategy might result in the treatment of many women who would not greatly benefit from a medication to improve bone density. Guidelines differ as to whether treatment should be instituted after fracture regardless of results of bone density testing. All major guidelines recommend, however, that if testing has not already been performed recently, it be done after fracture to determine disease severity and improve risk stratification. [11] [12] [13] [14] In this study, we performed a population-based study of women with hip fractures in 3 large states. 15 We examined whether differences in testing rates by race or socioeconomic status were present prior to fracture, and then whether there was any evidence of improvement in disparities after fracture.
METHODS

Data Sources
Eligible subjects were identified from a database containing all women eligible for Medicare in 3 states chosen for their large populations, for their racial and ethnic diversity, and because they are in different regions of the country: Florida, Illinois, and New York. Since July 1 1998, Medicare has paid for bone density tests for all postmenopausal women every 2 years. Medicare files examined included (1) the inpatient standard analytical file (SAF), which contains inpatient hospital claims; (2) the carrier SAF file, which is derived from claims for physician services; and (3) the denominator file, which contains demographic information. U.S. Census data were linked with the Medicare database to determine the population density and socioeconomic characteristics of the zip codes in which subjects resided. The institutional review board of the Medical College of Wisconsin approved the study design.
Study Population
Subjects were included in the study if they were female Medicare recipients who were residents of Florida, Illinois, or New York and had a fracture of the hip identified in claims during 2001, 2002 , or the first 6 months of 2003. To have complete information about bone mineral density (BMD) testing prior to fracture, subjects were required to be Medicare-eligible throughout January 1 1999- December 30 2003 and to be aged 65-89 years old in 1999.
We identified hip fractures by adapting a validated algorithm for identifying hip fractures using diagnostic [International Classification of Diseases, 9th edition (ICD-9)] and current procedural terminology (CPT) codes. 16 A complete description is included in the Appendix to the paper. In brief, patients with hip fracture were identified by ICD-9 code 820 or a procedure for hip fracture repair. Patients were excluded if the algorithm indicated that they were unlikely to have a hip fracture, for example, if they had no hip procedure and their codes for diagnoses came only from ambulatory settings or hospital admission, or if they had procedures that may be performed for other reasons (e.g., arthroplasty, which may be performed for osteoarthritis) and they had no fracture diagnosis. Subjects were excluded if they had end-stage renal disease, had primary bone or metastatic cancer, or were in a health maintenance organization that does not submit individual claims to Medicare. Subjects were also excluded if the subject could not be linked to a zip code (n=1,014) or if their race/ ethnicity was not white, black, or Hispanic.
Definitions of Variables
A primary outcome measure of "bone density assessment" was created using CPT and Health Care Financing Administration Common Procedure Coding System codes for axial and appendicular skeleton dual energy x-ray absorptiometry or computed tomography, peripheral (appendicular) ultrasound, or photodensitometry. The precision error of densitometry is likely to exceed the yearly bone loss for the average postmenopausal woman, 17, 18 so Medicare will reimburse bone density testing only every 2 years for postmenopausal women. Bone density assessment was therefore examined for a 2-year time interval before the fracture. We attempted to balance the potential physical difficulty patients might have with testing shortly after hip fracture with the importance of timely institution of therapy, which can reduce subsequent fracture risk in 1-2 years. We concluded that testing for patients who had not previously been tested should be performed within 6 months after fracture, the same time frame as in a previous study of osteoporosis medication use. 19 Bone density assessment was therefore examined for a 30-month interval from 2 years before to 6 months after the hip fracture. Using Medicare denominator files, patient race and ethnicity were categorized as white, black, or Hispanic. Using 2000 census data linked to the patient's zip code in the Medicare denominator file, we determined the median per capita income and the percent of all persons aged 25 and older who had completed high school in each subject's zip code. Subjects were assigned to tertiles of these variables. 20, 21 We examined patient age at the date of hip fracture (categorized in 5-year increments) and state of residence as found in the denominator files. Patient comorbidities identified from 2001 claims were measured using a comorbidity index of diagnoses and weights described by Charlson et al. 22 and adapted to outpatient ICD-9-CM diagnoses by Deyo et al. 23 and Klabunde et al. 24 Each patient was assigned to a category of 0, 1, or 2 or more comorbidities.
Analysis
Descriptive statistics were used to characterize the study sample, and differences by race/ethnicity were examined using Chi-square and t tests as appropriate. The percent of patients who received a bone density test within the 24 months prior to fracture, 6 months after the fracture, and at any time during this period was calculated. The unadjusted relationships of patient race and other patient variables with bone density testing in each time period were examined using the chi square test. We also developed a trichotomous logistic regression model using backward elimination of variables to examine whether there were differences by race, education, or income either before or after fractures occurred. Three outcomes were possible: never tested, tested within the 2 years prior to hip fracture, or not tested in the 2 prior years but tested in the 6 months after hip fracture. An outcome of bone density testing after fracture in this model would be conditional upon no receipt of testing in the 2-year interval prior to testing. The model included adjustments for patient age, state and urbanicity of residence, and comorbidity. Interactions between race, income, education, and all other variables were examined in this model. Results from the logistic regression model were converted from odds ratios to relative risk. 25 
RESULTS
The study examined 35,681 women with hip fractures, including over 1,000 black women and about 600 Hispanic women (Table 1 ). There were differences by race in age. Black and Hispanic women lived in lower-income and less-educated zip code areas and had greater comorbidity than white women.
Among the entire cohort, 20.7% of women had BMD testing during the 2 years prior to their fracture, and 6.2% additional women underwent BMD testing during the 6 months after the fracture, for a total of 26.9% who underwent testing during either time period. Racial differences in prefracture testing were prominent (Fig. 1) , with black women about half as likely and Hispanic women about 3/4 as likely as white women (21.1% tested) to have had testing in the 2 years prior to their fracture. In the 6 months after the fracture, the racial differences were less marked, but 6.3% of the original cohort of white women were tested, making them again more likely than black (4.6% of the original cohort) or Hispanic women (4.0% of the original cohort) to have testing after the fracture. Therefore, racial differences remained prominent in testing rates overall.
Differences in testing by income prefracture were also prominent ( Fig. 1) , as testing of women increased between 3 and 4% in a dose-dependent fashion from 17.0% for the lowerincome tertile to 24.2% for the upper-income tertile. After fracture, women in the lowest tertile of income were less likely (5.9%) than women in the middle (6.4%) or upper tertiles (6.2%) to have had testing. Differences in testing by education showed a similar pattern to income.
A logistic regression model (Table 2 ) was developed to allow the examination of the independent effects of race and socioeconomic factors on testing, controlling for age, comorbidity, and state of residence. In the 2 years prior to fracture, women of black race were about half as likely ( Older age was strongly associated with reduced testing at both time intervals. There was also marked regional variation in bone density testing at both time intervals; women who had a hip fracture in either Illinois or New York were less likely than those in Florida to receive testing. There were no significant interactions between race/ethnicity, income, or education and any other variables, including state of residence, in the regression analysis.
DISCUSSION
In this study of over 35,000 insured women with hip fractures, women of black race were 48% and women of Hispanic ethnicity were 34% less likely to undergo bone density testing over a 2-year period prior to fracture, even with adjustment for age and comorbidity. Although women of these races may have lower baseline risk of fracture, there was no "catch-up" in testing for women of black race and Hispanic ethnicity in the 6 months after fracture, at which point their propensity for fracture had been established. Women residing in areas with lower education and income were also less likely to undergo bone density testing before their fractures. However, the disparities by income and education were no longer present during the 6 months after hip fracture.
Our findings of lower use of BMD in women of black race and Hispanic ethnicity for primary prevention before a fracture confirm other reports in the literature, mostly from single institutions or health maintenance organizations. [1] [2] [3] 26, 27 These findings may have some legitimate explanations. Black and Hispanic women have a lower incidence of hip fracture and likely fewer fracture risk factors, and the predictive ability of BMD testing in these groups is not as well-studied as in white women. 5, 6 However, our findings that the disparities in primary prevention are not made up in testing for secondary prevention after fracture confirm a previous smaller report of 256 hip fracture patients in one health maintenance organi- zation who reported never receiving testing. 26 This disparity in testing after fracture cannot be easily justified, as existing professional guidelines [11] [12] [13] [14] clearly recommend testing after fracture, if it has not been performed earlier.
There are a range of patient and system-level factors previously shown to be involved in racial and ethnic disparities in medical care, and our study could not examine many of these. However, black women have previously been shown to be slightly older 28 and have more comorbid illnesses 29 at the time of their hip fractures, and we adjusted for both factors in our study. Any residual confounding effect, for example, from incomplete ascertainment of comorbidity because of our use of administrative data, would be unlikely to explain such large disparities. As fractures carry large risk of functional impairment and therapies can reduce fracture risk in a short time, current guidelines do not recommend variations in osteoporosis assessment by comorbidity. While we could not directly examine whether physician knowledge or even bias plays a role in our findings, evidence continues to mount that provider contributions to racial disparities can be important. 4, 30 It is possible that providers considering fracture prevention inappropriately apply population statistics to individual patients, a cognitive error sometimes also called misapplication of base rates or the ecological fallacy. 30, 31 If physicians overemphasize the differences in fracture risk by race/ethnicity, or perhaps perceive the risk in nonwhite women as so low as to be unimportant, they may reduce their attention to fracture prevention. In contrast to the findings for race and ethnicity, socioeconomic status measured at the neighborhood level appeared to act primarily on receipt of bone density tests before fracture. Women in our study all had Medicare insurance and, therefore, access to BMD testing throughout the study period. Our finding that racial disparities in BMD testing persisted after fracture, but socioeconomic disparities did not, suggests the possibility of different mechanisms for racial and socioeconomic disparities in BMD screening. There are many components to access to care; 32 for osteoporosis screening, availability of a bone densitometer and health care providers' knowledge of reimbursement for testing may both be important. It is possible that access improves in some ways after fracture for lower-income and lower-education women but not for Hispanic or black women. Nearly all women with hip fractures contact the health care system through hospitalization, and half are then institutionalized in a subacute facility at least short-term. 33 Hip fracture patients with lower income or less education, but not Hispanic or black patients, might have been more likely to receive bone density testing as they increased their contact with clinicians or care facilities experienced with geriatric care. To our knowledge, our study is the first to show a difference in the patterns of socioeconomic and racial osteoporosis testing disparities. Our study was limited by examination of only bone density testing and not treatment, and thus, we may have underestimated the attention paid to osteoporosis in some patients. However, our results are consistent with previous research into racial disparities in medication use after fracture. 19 It is possible that clinicians were aware that direct data on the relationship of bone density with fractures for black women was lacking at the time of our study. However, extensive epidemiologic data showed substantial rates of fracture among many nonwhite populations, clinical risk factors that work through lowering bone density had been shown to predict fractures in black women, 34 and several large randomized controlled trials of bisphosphonates 7, 8 had included nonwhite patients. Several studies published after the study period 5, 35 have confirmed the predictive ability of bone density for nonwhite patients. Our study is also limited by the relatively short time prior to fracture that was examined. However, as this study period began just after Medicare initiated reimbursement for bone density, any testing performed prior to this would have been reimbursed only through private insurance. Few of our study's population of older women would thus have had testing more than 2 years before the fracture, although women with fractures later in our study period would have had more opportunity. We could not ascertain reasons why bone density tests were not performed in this study, which might include patient preference, compliance with ordered tests, or access to care. Finally, education and income levels of all residents of a zip code are used as a proxy for individual socioeconomic status in this study. Although such measures may capture some important elements of community-level social deprivation, 36 they could not account for differences between the socioeconomic status of individuals and others living near them. In summary, in our study of women with hip fractures in 3 large states, we found that black and Hispanic women enrolled in Medicare are much less likely to undergo osteoporosis testing than their white counterparts. Of most concern, our study suggests that racial differences in osteoporosis care continue to occur even after a patient has demonstrated her propensity to fracture. It appears likely that physicians not only performed screening bone density tests at different rates for women of different races, but that they did not use hip fracture as a "signal" of bone fragility for patients of all races. Recent research showing the persistence of disparities in multiple types of medical care well into the 21st century 37 suggests that simply increasing awareness in the medical community is not enough to improve the disparities we identified. Our research further suggests that interventions may need to be different for racial/ethnic disparities than for socioeconomic disparities in osteoporosis care. Such interventions might include attempts to reduce individual medical provider bias and stereotyping, which show promise in the psychological literature. 4, 30 Interventions targeted at health systems, such as use of clinical pathways, have been successful in improving outcomes in several diseases 38 including primarily white patients with fragility fractures. 39 Further investigation is needed to determine whether similar interventions or combinations of interventions could reduce racial disparities and improve osteoporosis care for all.
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